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Understanding parents’ views toward the
newly enacted HPV vaccine school entry
policy in Puerto Rico: a qualitative study
Vivian Colón-López1,2*, Diana T. Medina-Laabes1, Roxana Soto Abreu1, Olga L. Díaz Miranda1, Ana P. Ortiz1,3,
María E. Fernández4 and Pamela C. Hull5

Abstract
Background: The Human papillomavirus vaccine (HPV) is an essential tool for the prevention of HPV-related
cancers. In Puerto Rico, the Secretary of Health established a school entry requirement of at least one dose of HPV
vaccination in girls and boys aged 11 and 12 years, taking effect in August 2018. Our study aimed to examine
parents’ and guardians’ views of unvaccinated children about the process of implementation of the new HPV
vaccination school entry policy in Puerto Rico and identify potential barriers and facilitators related to the
implementation of this requirement.
Methods: During April through November 2019, we conducted three focus groups (n = 12) and eight in-depth
semi-structured interviews with parents of children aged 11 and 12 who had not yet initiated the HPV vaccine
series. The interview topics addressed were: perception of vaccination, HPV vaccine and it is inclusion as new
school entry requirement practice, procedure of the sources of information, influencers, and willingness to change.
The interviews were recorded and transcribed by our staff members. We identified emergent themes through
thematic analysis.
Results: The participants’ perspective on the HPV vaccine school requirement was mixed. Lack of information of
the HPV vaccines and lack of communication about the school-entry requirement were the themes most
mentioned in the interviews. Moreover, previous negative experiences from friends or family members and adverse
effects deterred some participants from vaccinating their kids. We discussed barriers in the process of soliciting an
exemption.
Conclusion: Most barriers mentioned by study participants are modifiable. Information about the HPV vaccine
mandate’s implementation and educational materials regarding HPV vaccine safety need to be provided to address
parents’ concerns related to the vaccine’s side effects. Schools (teachers, principal directors, and administrative staff),
the government, and parent organizations need to be part of these efforts. This multilevel approach will help to
improve disseminating information about HPV vaccination to clarify doubts and misinformation among parents.
Keywords: HPV vaccine, School entry policy, Parental perspective, Hispanic
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Background
The HPV vaccine is a crucial tool for prevention against
human papillomavirus (HPV) and its related cancers. In
2018, the World Health Organization (WHO) made a
Call for Action to eliminate cervical cancer. This plan
includes 90% of the girls being full vaccinated with HPV
vaccine by age 15 years in 2030 [1]. A similar strategy
has been promoted by HealthyPeople 2030 in the United
States (US), which their goal is to achieve that 80.0% of
adolescents aged 13 through 15 years received recommended doses of the HPV vaccine [2]. However, recent
data from the 2019 National Immunization Survey
showed that adolescents aged 13–17 were 54.2% up-todate with the immunization series for HPV vaccine in
the US [3]. This result implies that the national HPV
vaccine uptake remained far from the goal.
As an evidence-based strategy, school-entry requirements have proved to increase vaccination rates among
children and youth [4]. The Advisory Committee on
Immunization Practices (ACIP) recommends the HPV
vaccine as a routine vaccine for girls (since 2006) and
boys (since 2011) at ages 11–12 years old [5]. Five US
states or territories (Virginia, District of Columbia,
Rhode Island, Puerto Rico, and Hawaii) implemented
the HPV vaccine as a requirement for school entrance
on those entering to 6 or 7 grades or started 11–12 years
old [6]. Even with these efforts at the policy level, parents’ negative beliefs and attitudes on childhood vaccination still remains a challenge [7].
Vercruysse and co-authors (2016) [8] found that most
parents from Northeastern states agreed with the
school-based HPV vaccination program, but they
showed weak support for making the vaccine a school
entry requirement. In this qualitative study, parental
choice and the unlikely casual-contact transmission of
HPV in the school setting were their primary reasons
against the mandate. A study in Connecticut in 2016 reported that parents did not expressed opposition to a
hypothetical HPV vaccination requirement and perceived that it would be similar to other routine vaccines
for school entry while also adding the benefit of cancer
prevention [9]. To our knowledge, only one qualitative
study [10] evaluated the parents’ perception of HPV vaccination mandate in Virginia, a state with HPV vaccine
requirement since 2009 [11]. Pitt et al. 2013 [10] found
resistance to the HPV vaccine mandatory from some
parents resulting in parental autonomy as the main barrier, followed by concern about the safety of this vaccine
[10]. Notably, few qualitative studies have evaluated the
parents’ perceptions regarding mandatory HPV vaccination for school entry in US states and territories.
In Puerto Rico (PR), cervical and oropharyngeal cancer
(in men) are the most common HPV-related cancers
[12]. Also, a recent study observed an increase in
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cervical cancer after evaluated the period 2001–2017
[13]. Under the PR’s Law #25 from September 25, 1983
(the Immunization Law), the PR government grants to
the Puerto Rico Secretary of Health (SHPR) the authority to decide which vaccine will be required for school
entry [14]. In August 2018, the SHPR established at least
one dose of the HPV vaccine was required for school entrance for girls and boys aged 11 and 12 years [15] to
prevent and reduce the incidence of HPV-related cancers in PR. Annually, the SHPR has amended this requirement for each school year (2018–2019: 11–12 years
old; 2019–2020: 11–14 years old, and 2020–2021: 11–16
years old) [16]. The purpose of this study was to examine the parents’ and guardians’ perception of unvaccinated children about the process of implementation of
the new HPV vaccination school entry policy in PR, and
identify potential barriers and facilitators related to this
requirement.

Methods
Study design and sample

The implementation of school-entry policy for HPV vaccination (HPV-PIVac study) is a prospective study to
understand geographic variation in HPV vaccine policies
and outcomes across US states and territories, and
studying the implementation and impact of the new
school-entry HPV vaccine policy in PR. As part of this
study, we conducted a a qualitative study between April
to November 2019, 8–15 months after the HPV schoolentry policy took effect in PR. Eligible criteria were: (1)
parents or guardians (i.e., participants) (2) of boys and
girls aged 11 and 12 years old who have not initiated the
HPV vaccine series at the time of the interview, and (3)
lives in San Juan or surrounding municipalities (Carolina, Trujillo Alto, Guaynabo, Caguas or Aguas Buenas).
We recruited 20 participants for the focus groups of a
total of 40 screened. Fifty percent of those screened did
not participate in the study because of time availability,
loss of contact, or they vaccinated their child before the
interview. All the recruited participants were women between the ages of 23 to 68 years old and mainly residents
of the municipality of San Juan (80%); 18 reported being
mothers and two grandmothers. Twelve participants
were interviewed in focus groups (two focus groups,
each with 2 participants and one focus group with 8),
and eight participants were in-depth interviews.
Recruitment

We used a purposive sampling. Several strategies were
used to recruit the study participants. First, we posted
flyers with information from the study in clinical settings, including Federally Qualified Health Clinics,
pediatric clinics, and hospitals. Also, we distributed
flyers to parents in several activities in the community
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and schools (sports, health fair, organic food fair, and social activities). We briefly discussed face-to-face with
them (if requested), information of the study (study objectives), and their expected role in this study. We asked
for contact information among those who were interested. Moreover, we conducted door-to-door outreach
in public housing complexes. Their community leaders
and the social workers collaborated to identify potential
participants. All these venues were located in San Juan
and surrounding municipalities. Lastly, we posted recruitment materials on Facebook to promote the study
and increase engagement. A staff member screened
those potential participants interested in our study by
phone to determine their eligibility by a staff member.
We scheduled the interview according to the participants’ time availability and the dynamics that made them
feel more comfortable to speak (focus group or in-depth
interview). Data were not affected because we used the
same guideline for both methods, focus group and indepth interview.
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in-depth interviews lasted around 20–40 min. Of three
focus groups, two were held in a private conference
room in the University of Puerto Rico Comprehensive
Cancer Center (UPRCCC). The other focus group was
conducted in a private room in a public housing complex. Two trained staff were in each focus group. One
was responsible for guiding the interview, and another
person to take notes. The in-depth interviews were faceto-face (in the UPRCCC) or over the phone, using the
same dynamic as the focus group regarding the staff.
Participants received $25.00 to compensate for their
time. Incentives were provided in-person or sent by certified postal mail. All the data collected through the interviews (focus groups and in-depth) were audiorecorded and transcribed verbatim in the same language
as the interview. A separate staff member reviewed the
transcriptions for validation. For this publication, quotes
were translated into English.

Data analyses
Data collection procedures

A trained staff discussed the informed consent one-toone with the participants, by telephone or in-person. All
participants signed the informed consent. The participants who preferred telephone interviews, informed consent was sent by email.
Questionnaire

Before the interview, a questionnaire, in Spanish, with
closed-ended questions were administrated to each participant to gather parent’s demographic information
(gender, age, marital status, level of education, income
and religious preference); children’s information (gender,
health insurance, type of school and vaccination record);
awareness of the HPV vaccine and its inclusion as
school-entry vaccine requirement. The questionnaire
was developed and collected in Qualtrics (SAP, Utah/Seattle, US).
Focus group and in-depth interview

We used the same semi-structured interview guideline
for the focus groups and in-depth interviews (see supplementary document), with open-ended questions that
prompted participants to discuss the following topics:
perception of vaccination in general, HPV vaccine, and
the new school entry requirement policy; practice and
procedure of the sources of information; influencers;
and willingness to change. We gave fictitious names to
those participants on the focus group and a random
number for those who participated in in-depth interviews to protect their identities. Both focus groups and
in-depth interviews were conducted in Spanish by the
training staff. Focus groups lasted 40–60 min, and the

Qualitative data management and analysis were performed using Atlas.ti 8.0 (Scientific Software Development GmbH, Berlin, Germany). We used thematic
analysis to identify, analyze, and report themes [17].
First, one of the members (DML) performed the initial
coding, and another member (VCL) reviewed the identification of the codes derived from the data and the
quotes linked to the codes. Second, both members
reviewed the codes several times until they met a consensus to define them and determine the emerging codes
[18, 19]. We evaluated each interview separately for the
coding process, and then we combined them to classify
the codes by theme. Twenty-three codes were identified
and organized into five themes (Attitudes and Beliefs,
Knowledge, Communication, Barriers, and Recommendations). We used descriptive statistics to summarize the
quantitative data from the questionnaire.

Results
According to the questionnaire, most participants reported having less than some college education (70.0%)
and an annual income of less than $15,000 (68.4%). The
vast majority of the participants’ children were enrolled
in public school (80.0%) and had Medicaid government
health insurance (70.0%). The majority (80.0%) of the
participants heard about the HPV vaccine, mainly
through health providers. Despite this, over half of them
(55.0%) were unaware that the HPV vaccine was a
school-entry requirement. In addition, 13 of 20 participants reported that they vaccinated their children with
all the required vaccines for school except HPV vaccine
(Table 1).

Colón-López et al. BMC Public Health

(2021) 21:1938

Table 1 Characteristics of Focus Groups and In-Depth
Interviews Participants: HPV-PIVac Study 2019 (n = 20)
Characteristics

Frequency
n (range or %)

Age (mean)

41 (range: 23–68)

Education
Some college or more

6 (30.0)

Less than some college

14 (70.0)

Incomeα
≥ $15.000

6 (31.6)

< $15.000

13 (68.4)

School
Public

16 (80.0)

Private

4 (20.0)

Child’s health insurance
Medicaid

14 (70.0)

Private

5 (25.0)

Non-insurance

1 (5.0)

How important is your religious beliefs?
Important or very important

16 (80.0)

Little important or unimportant

4 (20.0)

What required vaccine the children had, except HPV vaccine?
All of them α

13 (65.0)
7 (35.0)

Some of them
Who told you about HPV vaccine?

β

Health Provider

9 (45.0)

School

7 (35.0)

Family member

4 (20.0)

TV commercial

8 (40.0)

Unknown about the HPV vaccine

4 (20.0)

Did you know that HPV vaccine was included as vaccination requirement
for starting school?
No

11 (55.0)

Yes

9 (45.0)

If the HPV vaccine is required for the entry school, as parent, what will you
do?
Vaccinate my son/daughter

9 (45.0)

Depending on the doctor recommendation

4 (20.0)

Sign a vaccine exemption

5 (25.0)

Need more information to take a decision

2 (10.0)

α: Tdap, meningococcal vaccine, Polio, MMR, VAR, Hib, Hepatitis B
β: the participants chose more than one option

Participants’ attitudes and beliefs mixed regarding HPV
vaccine school entry policy

In general, almost all the participants stated that vaccination is a positive preventive method against diseases, although few had doubts about their efficacy and safety.
Participants’ perception of including the HPV vaccine as
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a school entry requirement was mixed. Half of the participants expressed being in favor. Some participants
mentioned that this policy might ensure early protection
against the HPV infection or future cancer development.
Two participants (grandparents) agreed with the HPVschool entry requirement. These guardians witnessed in
the past the mortality caused by now preventable diseases due to limited access to treatment.
Those who hesitated to the HPV vaccine requirement
mentioned different reasons: administration at an early
age, distrust in the efficacy and safety of the vaccine, and
parental autonomy. Participants hesitated by the age
(11–12 years old) of the mandate did not wholly reject
the intention to vaccinate their children. Instead, they
thought of vaccinating their children when they get
older.
“I think that if he is not sexually active … I think
that [when] he turns 15 years old, he can be [vaccinated]. [W] hen he [can] understand, and we can
talk about that topic. [A] 11 and 12 [year-old] boy
[does] not [understand] what the vaccine is for or
what it uses for.”
The participants commonly expressed previous negative experiences with the HPV vaccine or other vaccine
from friends or family members in the interviews. In
some participants, these anecdotes caused them uneasiness about the safety and effectiveness of the HPV vaccine since it was a “new” vaccine for them. Other
participants disclosed their children’s pre-existing medical conditions, indicating their concerns about how the
vaccine’s components and its potential adverse effects
could exacerbate their children’s health condition.
HPV vaccine knowledge and unawareness about the HPV
school entry policy

Most of the participants were aware of how many doses
are required to complete the series and that HPV is a
sexually transmitted disease. Few mentioned the association between this vaccine and cancer prevention. Despite their knowledge about the vaccine, some
participants indicated that they had never heard about
the new HPV vaccine school entry requirement. One
participant expressed the constant promotion of this
vaccine through the mass media (TV, Facebook, newspaper). Still, she never noticed it in the immunization
record (commonly known in PR as the ‘green sheet’) required for the school entry.
“A lot of promotion about the [HPV] vaccine, but I
did not know that it was mandatory to vaccinate
them for school, [I mean], that it existed in the green
sheet of vaccines …. “.
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Lack of communication: the main barrier for school-entry
policy

The participants’ main barrier regarding the HPV vaccine requirement policy was the communication between the parents, the schools and health provider.
Participants expressed that the information provided by
the school, mainly during the school enrollment process,
was general in content: a paper with a list of all the materials, vaccination requirements, and a request of a
medical evaluation if it applies. They also argued that
their children’s schools lacked educational opportunities
or a space for explaining or clarifying doubts about the
vaccine requirement. Only two participants remembered
receiving a notification from the school about the HPV
vaccine being including in immunization requirements.
Some participants expressed that the school nurse called
them to remind them about the deadline to vaccinate
their child without further explanation.
Although most participants indicated that they received information about the HPV vaccine and its school
requirement from their healthcare providers, most of
them verbalized that the experience was insufficient.
Some participants said that the only information they received from pediatricians was that “it is mandatory” or
“you need it for school”.
“[When] you go to a pediatrician’s office, the only
thing that they tell you is that you have to give [to
your child] the vaccine, and that’s it!”
In contrast, participants who decided to request a
medical exemption indicated that their providers talked
to them about vaccination. In this conversation, the provider explained the pros and cons of the HPV vaccine
and whether the child’s condition could be compromised
after the vaccine administration. One participant felt that
her privacy was respected when her health provider
talked with her because it was a ‘closed-door’ conversation and he did not judge her.
Almost all the participants discussed the TV advertisements seen regarding the HPV vaccine. For some participants, these TV advertisements were the only source to
get information about the HPV vaccine. Others
expressed that the sense of guilt the advertisement promoted made them feel blame for their children’s future.
“TV blames you and makes you a bad parent. The
ad blames you and makes you a bad parent.”
Interestingly, this advertisement made some of them
think to eventually vaccinate their children because if
they can prevent something wrong happened to their
child, they will do it. Moreover, Facebook and the internet were the tools used by these participants to find
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information about vaccines. However, they stated that
they were aware that the information found on social
media and websites would not necessarily be accurate.
Barriers regarding HPV vaccine and exemption

The lack of information about the HPV vaccine was another barrier identified. The main topics regarding lack
of information were the pros and cons of the HPV vaccination to be required, and concerns about what happened if the vaccination series is interrupted. Other
concerns expressed were alleged associations with autism, paralytic effects, an allergic reaction, and deathly
consequence. Most of the participants said that seeing,
listening, or reading this kind of (mis) information made
them mistrust the HPV vaccine.
“I talked with other parents and hearing news too,
and all those things, like increasing [my doubts] and
make me not want to allow [my child] to get the
vaccine.”
Access to the vaccine, availability to coordinate an appointment, and the cost of getting the immunization
record signed by the health provider were also barriers
mentioned. Two participants mentioned the high price
of the vaccine as a general issue but not directly impacted. Three participants indicated that they went
through the process of obtaining a medical exemption
for the HPV vaccine. Complexity and the cost of the
process affected their intent to get the exemption. They
explained that it was a tedious and bureaucratic procedure to identify a healthcare provider or religious leader
who would attest to the exemption and then find and
coordinate an appointment with a lawyer to sign the affidavit. Exemptions from vaccination require to be
renewed every year in PR. Therefore, parents had to
incur the cost and go through these efforts every year.
“ If it’s necessary, I’ll do it again [to avoid] putting
things in my daughter that I do not consider
necessary.”
Recommendations

The participants did not mention facilitators in their interviews. However, they recommended two primary information sources: schools and health care providers.
Both should educate about the HPV vaccine and its requirement for school entry. The participants suggested
that schools should be more proactive in providing educational sessions for parents and students whenever
there are new changes to the requirements for schoolentry. The participants said that health care providers,
specifically those who administer vaccines, should be
aware of the components of vaccines, their benefits, and
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potential adverse effects to explain this information to
parents who have questions. Other recommendations
from the participants were the sources’ message should
not focus on using the fear factor, and to use social
media and mass media to inform the community.
“[In] the orientation, the pros and cons have to be
indicated but not using the fear factor to impose or
obligate a person to vaccinate [her/his] child.”

Discussion
In August 2018, PR was the 4th state/territory of the US
to enact an HPV vaccine mandate for school entry [6].
We collected our data a couple of months after the
Puerto Rico Department of Health (DOH) implemented
this new policy. According to our results, in this group
of parents and guardians of unvaccinated children, their
views regarding the HPV vaccine school policy were
mixed. Participants mentioned the vaccine’s benefits
(i.e., prevention for cancer and HPV infection), and
others said they disagreed because of the policy’s age
and the mandatory aspect. The most emergent themes
were a lack of communication about the school entry
policy and information about the HPV vaccine. Despite
the participants not mentioning any facilitator related to
implementing the HPV vaccine school requirement during their interviews, they all indicated their
recommendations.
Early age, parental autonomy, and concerns about vaccine safety were reasons that some hesitant participants
mentioned in disbelief of the vaccine and the implementation. Hispanic parents recruited from other studies
expressed this same concern of the age recommended
for the HPV vaccine and often linked it with sexual activity [20–22]. ACIP recommended administration of
HPV vaccine at 11–12 years old because it showed a robust immune response [5]. The scientific literature did
not find evidence among the reviewed of several studies
regarding an association between the HPV vaccine and
promiscuity [23, 24]. Congruent to our qualitative analysis, 45% of our participants reported interest to vaccinate their child against HPV vaccine if it was a
requirement. These results are consistent with a systematic analysis showed that parents’ agreement with the
HPV school-entry mandate ranged from 27 to 63.5%
[25]. Those against the potential future mandate stated
the following arguments: limited information about the
requirement, age, and lack of parental autonomy and
those in favor were regarding prevention [25]. These arguments are similar to our participants’ opinions. However, the studies included in this analysis were
conducted almost a decade ago. Also, one was in
Guyana and the others were in states of the US (Georgia,
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Massachusetts, and Mississippi) who had not the HPVschool entry policy [10].
Vaccine hesitancy is defined as either refusal, delay in
getting vaccinated or accepting vaccination with concern
[26, 27]. In our study, the hesitation to the HPV vaccine
among participants did not necessarily translate to hesitation about other adolescent immunizations or refusal
of all required vaccines. Thirteen of the 20 participants
reported that their children had all the other vaccines required for the school, except the HPV vaccine. More
than half of our participants were unaware of the policy;
despite the DOH providing information to the public a
year prior (June 2017) [14]. The lack of awareness and
difficulty accessing the HPV vaccine were the other reasons for some of our participants have not vaccinate
their child at the time of the interview.
All our participants mentioned personal stories or
negative experiences from someone regarding the adverse effects of the vaccines. MacDonald and co-authors
[26] have suggested that factors associated with vaccine
hesitancy are individual and group influence based on
personal perception, personal experience, and the social
media. Previous negative experiences with a vaccine
could lead a parent to be hesitant and mistrust the effectiveness and safety of the vaccination in general [28].
For vaccine requirements, these negative vaccination experiences could directly affect the compliance of the
mandate. Unfortunately, when these stories get disseminated via social media, people rely more on anecdotal,
experience-based information than evidence-based information [7]. Besides, the spread of misinformation
through these media could get more impact due to easy
access. Understanding the scope and variability of the
current sentiment toward the HPV vaccine and its policy
could inform the development of an education campaign
to combat the harmful misinformation using these same
delivery channels [29, 30].
The lack of communication between the parents and
guardians with the school and health providers was the
main barrier to the HPV vaccine school entry policy.
Similar to our studies [21, 30, 31], parents have recommended workshops in a school setting given the accessibility. Having trained school personnel and integrate
parents and students, the school could improve the engagement with the HPV vaccine policy [32]. Therefore,
assess the school staff’s role (e.g., the school nurse,
school principal, teachers), attitude, beliefs, and impact
in vaccination school policy could strengthen the importance of integrating them in these preventive efforts.
Regarding the communication with the health providers,
several participants described it as insufficient. According to the participants’ discussion, the health provider
mentioned that the HPV vaccine was mandatory for
school entry without more explanation. The literature
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suggests that insufficient or inadequate communication
between parents and health providers could negatively
influence parents’ decisions and contribute to hesitant
behavior [33, 34]. The influence of the healthcare providers’ recommendation has on the parents’ decisions on
vaccination uptake (in general) is constantly reported
[33–37]. This is also consistent with a previous household survey in PR conducted prior to the requirement
(2008), in which 89% of parents of daughters in vaccine
recommended age groups reported that they would vaccinate them if the doctor recommended it [37]. Strategies continually developed for the healthcare providers
could provide effective communication and build trust
with parents to recommend vaccination [34, 38].
In our studies, the lack of information was a barrier regarding the HPV vaccine, which could affect the HPV
vaccine mandate. Consistent with our findings, two studies that evaluated a group of Latina mothers found a low
level of knowledge about cervical cancer, HPV infection,
and HPV vaccine [21, 22]. Gualano et al. [25]
highlighted that limited knowledge on HPV vaccine
could be associated with the opposition of the
mandatory HPV vaccination. Despite this limitation, our
participants expressed their interest in knowing about
the pros and cons of the requirement of HPV vaccine
for school entrance, duration of vaccine effectiveness,
and potential side effects to make an informed decision
about vaccinating against HPV. Studies have shown this
same parents’ interest for more information before considering vaccinate their child [20–22, 39].
Some of our participants expressed limited access to
the HPV vaccine. A possible explanation of this limitation was the long-term recovery of several immunization
clinics after the impact of Hurricane Irma and Hurricane
María in PR [40]. Barriers regarding immunization exemptions are poorly studied topics. The participants
who required the exemption in our study mentioned the
difficulties of the process and the cost. The DOH has a
strict exemption requirement as it only allows medical
and religious exemption for vaccination (no philosophical exemption) [14]. The rate of exemption in PR is still
unknown. Further efforts need to explore if exemption
requests have increased in PR due to the implementation
of the HPV vaccine since August 2018 and how (if any)
impacted the uptake of other adolescent vaccines over
time.
Strengths and limitations

Mandatory vaccination for school entry is a strategy to
increase vaccination uptake, make catch-up, or reduce
the gap between vaccine groups, including the HPV vaccine [41]. To our knowledge, this is the first qualitative
study in PR that describes parental perspectives about
the HPV vaccine school entry requirement and portrays
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challenges in the exemption process. Our study is one of
two studies [10] that evaluated the parental perspective
about the HPV vaccine policy enacted on a US territory.
Regardless of this effort, our research has several limitations worth discussing. The size of the sample and convenience sampling did not allow for the generalization of
the results. In addition, a population-level profile of
those parents who delay or reluctant to refuse the HPV
vaccination in PR does not exist. Our sample is similar
in education level, income, and health insurance compared to the Puerto Rican general population [42]. Despite several outreach and community engagement efforts
performed, we recruited a relatively small sample of participants. The narrow eligibility requirements made this
a hard-to-reach population for recruitment, given that
PR has a high HPV vaccine initiation rate (75.7%) among
teenagers [43]. Participants’ time availability and concerns of being exposed to the public spotlight (due to
their views on vaccination) were barriers to recruitment.
However, we highlighted those in-person recruitment
strategies (e.g., visiting public housing complexes and
distribute flyers in activities, both with the opportunity
to do a brief discussion) were more effective (17/20 participants) than Facebook or flyers from a desk. For some
participants, in-depth interview was more comfortable
because they could open up more about their view of
the school policy and HPV vaccine. We opened our recruitment for female and male parents; however, only females participated. Understand the fathers’ perception
could help us getting additional insight on vaccines and
this new requirement and understand potential divergent family dynamics in the decision of vaccinating (or
not) their children against HPV [44].

Conclusion
We conducted this study in a timely opportunity to
understand the parental perceptions regarding the implementation of this recent HPV vaccine requirement.
Most of the barriers identified could be modifiable addressing with targeted educational programs with parents, school staff and providers, health communication
strategies across agencies responsible for the implementation, public acceptability, and political acceptability to
support this policy [29, 31, 45]. According to unpublished preliminary results using data of 2010 through
2019 provided by the Puerto Rico Immunization Registry
and our research team, an increase of 54% was observed
in HPV vaccination initiation rate (not completion) for
11–12 years old children after implementing the requirement [46]. However, it is unknown how the COVID-19
pandemic has impacted the parental perception of the
school required vaccines and HPV vaccine uptake. Future research could explore target educational interventions that might help address and boost parental
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concerns, maintain a high rate of the first dose, and increase completion and adherence to the HPV vaccine
schedule of the second dose. Also, it is important to
understand the barriers between a parent who refuse in
comparison to a parent who delayed the vaccination
could be differents [47]. Understanding the progression
of parental perceptions throughout the policy implementation, and how current scenarios might impact their decisional process should help us to develop effective
interventions that respond to the identified barriers and
facilitators in the future.
Abbreviations
HPV: human papillomavirus; WHO: World Health Organization; US: United
States of America; ACIP: Advisory Committee on Immunization Practices;
PR: Puerto Rico; SHPR: Puerto Rico Secretary of Health.; DOH: Puerto Rico
Department of Health

Supplementary information
The online version contains supplementary material available at https://doi.
org/10.1186/s12889-021-11952-w.
Additional file 1. GUÍA DEL MODERADOR: ENTREVISTA A PADRES O
ENCARGADOS. Description of data: This document is the guideline
questions used for the focus group and in-depth interview in our study.

Page 8 of 9

Declarations
Ethics approval and consent to participate
After discussing the informed consent form and agreed with the study, this
was signed by all study participants. All these methods followed relevant
guidelines, literature review, and regulations approved by the Institutional
Review Board (IRB) of the University of Puerto Rico, Medical Sciences
Campus (protocol A8060218).
Consent for publication
Not applicable.
Competing interests
VCL has received compensation from Merck and Co., Inc. for consultancy in
June 2020. APO received personal fees from serving as a consultant for
Merck (October 2019) outside the submitted work. The other authors have
declared that they have no competing interest.
Author details
1
Comprehensive Cancer Center-University of Puerto Rico, Cancer Control and
Population Sciences, San Juan, Puerto Rico. 2Department of Health Services
Administration, Graduate School of Public Health, University of Puerto Rico
Medical Science Campus, San Juan, Puerto Rico. 3Department of
Epidemiology and Biostatistics, Graduate School of Public Health, University
of Puerto Rico Medical Science Campus, San Juan, Puerto Rico. 4Department
of Health Promotion and Behavioral Sciences, University of Texas Health
Science Center, Houston, Texas, United States. 5The University of Kentucky,
Department of Behavioral Science, College of Medicine, Markey Cancer
Center, Lexington, Kentucky, United States.
Received: 9 March 2021 Accepted: 28 September 2021

Acknowledgments
This publication was supported by the Comprehensive Cancer Center of the
UPR (a public corporation of the Government of Puerto Rico created in
virtue of Law 230 of August 26, 2004, as amended). The content is entirely
the authors’ responsibility and does not necessarily represent the official
views of the Comprehensive Cancer Center UPR. We thank Dr. Katelyn Wells,
Manuel E Rivera, Vilnery Rivera Figueroa and, Glizette Arroyo Morales for your
support and collaboration.
Authors’ contributions
VCL was funding acquisition, supervision, conceptualization, methodology,
writing-original draft preparation, investigation, and validation. DTML’s contribution was methodology, writing-original draft preparation, formal analysis,
and investigation. RSA’s contribution was methodology, formal analysis, investigation, writing- reviewing, and editing. ODM’s contribution was formal
analysis, investigation, writing- reviewing, and editing. APO’s contribution
was writing- reviewing and editing. MF’s contributions were writing reviewing and editing. PCH’s contribution was funding acquisition, formal analysis,
investigation, writing- reviewing, and editing. The author(s) read and approved the final manuscript.
Funding
This work was supported by National Cancer Institute (NCI), grant
R01CA232743-01A1 (“Implementation of School-Entry Policies for Human
Papillomavirus Vaccination”) within University of Puerto Rico Comprehensive
Cancer Center. The National Cancer Institute had no role in the study design;
collection, analysis, and interpretation of the data; writing of the manuscript;
or decision to publish. The content is solely the responsibility of the authors
and does not necessarily represent the official views of the NCI.
Availability of data and materials
The data sets generated and analyzed during the current study are not
publicly available due to our confidentiality commitment to our participants
to keep such data in our offices, but they are available from the
corresponding author on reasonable request and after being discussed with
the IRB.

References
1. World Health Organisation. In: Global Strategy to Accelerate the Elimination of
Cervical Cancer as a Public Health Problem and Its Associated Goals and
Targets for the Period 2020–2030, vol. Vol 2; 2020.
2. Healthy People 2030. Increase the proportion of adolescents who get
recommended doses of the HPV vaccine — IID-08. https://health.gov/hea
lthypeople/objectives-and-data/browse-objectives/vaccination/increaseproportion-adolescents-who-get-recommended-doses-hpv-vaccine-iid-08.
Published 2021. Accessed 5 Feb 2021.
3. Elam-Evans LD, Yankey D, Singleton JA, et al. National, Regional, State, and
Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17
Years — United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):
1109–16. https://doi.org/10.15585/mmwr.mm6933a1.
4. Greyson D, Vriesema-Magnuson C, Bettinger JA. Impact of school
vaccination mandates on pediatric vaccination coverage: a systematic
review. C Open. 2019;7(3):E524–36. https://doi.org/10.9778/cmajo.20180191.
5. Meites E, Kempe A, Markowitz LE. Use of a 2-dose schedule for human
papillomavirus vaccination—updated recommendations of the advisory
committee on immunization practices. Am J Transplant. 2017;17(3):834–7.
https://doi.org/10.1111/ajt.14206.
6. National Conference of State Legislatures. HPV Vaccine: State Legislation
and Regulation. https://www.ncsl.org/research/health/hpv-vaccine-statelegislation-and-statutes.aspx. Accessed 17 May 2021.
7. Dubé E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the
anti-vaccine movement: influence, impact and implications. Expert Rev
Vaccines. 2014;14(1):99–117. https://doi.org/10.1586/14760584.2015.964212.
8. Vercruysse J, Chigurupati NL, Fung L, Apte G, Pierre-Joseph N, Perkins RB.
Parents’ and providers’ attitudes toward school-located provision and
school-entry requirements for HPV vaccines. Hum Vaccin Immunother. 2016;
12(6):1606–14. https://doi.org/10.1080/21645515.2016.1140289.
9. Ogunbajo A, Hansen CE, North AL, Okoloko E, Niccolai LM. “I think they’re
all basically the same”: parents’ perceptions of human papilloma virus (HPV)
vaccine compared with other adolescent vaccines. Child Care Health Dev.
2016;42(4):582–7. https://doi.org/10.1111/cch.12331.
10. Pitts MJ, Adams TK. Implications of the virginia human papillomavirus
vaccine mandate for parental vaccine acceptance. Qual Health Res. 2013;
23(5):605–17. https://doi.org/10.1177/1049732312470871.

Colón-López et al. BMC Public Health

(2021) 21:1938

11. Horlick G, Shaw FE, Gorji M, Fishbein DB. Delivering New Vaccines to
Adolescents: The Role of School-Entry Laws. Pediatrics. 2008;
121(Supplement 1):S79–84. https://doi.org/10.1542/peds.2007-1115I.
12. Torres-Cintrón CR, Alvarado-Ortiz M, Roman-Ruiz Y, Ortiz-Ortiz KJ, Zavala
Zegarra DE, Tortolero-Luna G. Cancer in Puerto Rico, 2012–2016. San Juan:
Puerto Rico Central Cancer Registry; 2016.
13. Ortiz AP, Ortiz-Ortiz KJ, Colón-López V, Tortolero-Luna G, Torres-Cintrón CR,
Wu CF, et al. Incidence of cervical Cancer in Puerto Rico, 2001-2017. JAMA
Oncol. 2020;7(3):456–8. https://doi.org/10.1001/jamaoncol.2020.7488.
14. Vázquez-Otero C, Daley EM, Vamos CA, Romero-Daza N, Beckstead J,
Martinez TD. The intersection of problems, policy, and politics: the adoption
of an HPV vaccine school-entry requirement in Puerto Rico. Qual Health Res.
2021;31(5):859–70. https://doi.org/10.1177/1049732321991507.
15. The Associated Press. Puerto Rico orders students to get vaccinated against
HPV. Carribean Business. https://caribbeanbusiness.com/puerto-rico-ordersstudents-to-get-vaccinated-against-hpv/?cn-reloaded=1. Accessed 13 Mar
2020.
16. División de Inmunización (Vacunación) _ Departamento de Salud de Puerto
Rico.
17. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol.
2006;3(2):77–101. https://doi.org/10.1191/1478088706qp063oa.
18. Stemler S. An overview of content analysis. Pract Assessment, Res Eval. 2001;
7(17):2000–1. https://doi.org/10.1362/146934703771910080.
19. Park H, Park B, Choi EJ, et al. Factors influencing vaccination in Korea:
findings from focus group interviews. J Prev Med Public Heal. 2018;51(4):
173–80. https://doi.org/10.3961/jpmph.18.063.
20. Albright K, Barnard J, O’Leary ST, et al. Noninitiation and noncompletion of
HPV vaccine among English- and Spanish-speaking parents of adolescent
girls: a qualitative study. Acad Pediatr. 2017;17(7):778–84. https://doi.org/10.1
016/j.acap.2017.03.013.
21. Btoush R. Brown DiR, Tsui J, Toler L, Bucalo J. knowledge and attitudes
toward human papillomavirus vaccination among Latina mothers of south
American and Caribbean descent in the eastern US. Heal Equity. 2019;3(1):
219–30. https://doi.org/10.1089/heq.2018.0058.
22. Fernández ME, Le YCL, Fernández-Espada N, et al. Knowledge, attitudes, and
beliefs about human papillomavirus (HPV) vaccination among Puerto Rican
mothers and daughters, 2010: a qualitative study. Prev Chronic Dis. 2014;
11(12):140171. https://doi.org/10.5888/pcd11.140171.
23. Bednarczyk RA. Addressing HPV vaccine myths: practical information for
healthcare providers. Hum Vaccines Immunother. 2019;15(7–8):1628–38.
https://doi.org/10.1080/21645515.2019.1565267.
24. Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher
RL. Factors associated with HPV vaccine uptake in teenage girls: a
systematic review. Vaccine. 2012;30(24):3546–56. https://doi.org/10.1016/j.va
ccine.2012.03.063.
25. Gualano MR, Olivero E, Voglino G, Corezzi M, Rossello P, Vicentini C, et al.
Knowledge, attitudes and beliefs towards compulsory vaccination: a
systematic review. Hum Vaccines Immunother. 2019;15(4):918–31. https://
doi.org/10.1080/21645515.2018.1564437.
26. MacDonald NE, Eskola J, Liang X, et al. Vaccine hesitancy: definition, scope
and determinants. Vaccine. 2015;33(34):4161–4. https://doi.org/10.1016/j.va
ccine.2015.04.036.
27. Domek GJ, O’Leary ST, Bull S, et al. Measuring vaccine hesitancy: field
testing the WHO SAGE working group on vaccine hesitancy survey tool in
Guatemala. Vaccine. 2018;36(35):5273–81. https://doi.org/10.1016/j.vaccine.2
018.07.046.
28. Rozbroj T, Lyons A, Lucke J. Vaccine-hesitant and vaccine-refusing parents’
reflections on the way parenthood changed their attitudes to vaccination. J
Community Health. 2020;45(1):63–72. https://doi.org/10.1007/s10900-01900723-9.
29. Olson O, Berry C, Kumar N. Addressing parental vaccine hesitancy towards
childhood vaccines in the United States: a systematic literature review of
communication interventions and strategies. Vaccines. 2020;8(4):1–25.
https://doi.org/10.3390/vaccines8040590.
30. Aragones A, Genoff M, Gonzalez C, Shuk E, Gany F. HPV vaccine and Latino
immigrant parents: if they offer it, we will get it. J Immigr Minor Health.
2016;18(5):1060–5. https://doi.org/10.1007/s10903-015-0225-x.
31. Ramanadhan S, Fontanet C, Teixeira M, Mahtani S, Katz I. Exploring attitudes
of adolescents and caregivers towards community-based delivery of the
HPV vaccine: A qualitative study. BMC Public Health. 2020;20(1):1531. https://
doi.org/10.1186/s12889-020-09632-2.

Page 9 of 9

32. Kaul S, Do TQN, Hsu E, Schmeler KM, Montealegre JR, Rodriguez AM.
School-based human papillomavirus vaccination program for increasing
vaccine uptake in an underserved area in Texas. Papillomavirus Res. 2019;8:
100189. https://doi.org/10.1016/j.pvr.2019.100189.
33. Williamson L, Glaab H. Addressing vaccine hesitancy requires an ethically
consistent health strategy. BMC Med Ethics. 2018;19(1):84. https://doi.org/1
0.1186/s12910-018-0322-1.
34. Kaufman J, Ryan R, Walsh L, Horey D, Leask J, Robinson P, et al. Face-to-face
interventions for informing or educating parents about early childhood
vaccination. Cochrane Database Syst Rev. 2018;5(5):CD010038. https://doi.
org/10.1002/14651858.CD010038.pub3.
35. Lockhart S, Dempsey AF, Pyrzanowski J, O’Leary ST, Barnard JG. Provider and
parent perspectives on enhanced communication tools for human
papillomavirus vaccine–hesitant parents. Acad Pediatr. 2018;18(7):776–82.
https://doi.org/10.1016/j.acap.2018.05.012.
36. Romaguera J, Caballero-Varona D, Tortolero-Luna G, Marrero E, Suárez E, Pérez
CM, et al. Factors associated with HPV vaccine awareness in a populationbased sample of hispanic women in Puerto Rico. J Racial Ethn Heal Disparities.
2015;3(2):281–90. https://doi.org/10.1007/s40615-015-0144-5.
37. Reyes JC, Sánchez-díaz CT, Tortolero-luna G, Colón HM, Ortiz AP.
Demographic and High-Risk Behaviors associated with HPV and HPV
Vaccine Awareness among Persons Aged 15–74 Years in Puerto Rico. P R
Health Sci J. 2015;34(4):195–200.
38. Calo WA, Gilkey MB, Shah PD, Moss JL, Brewer NT. Parents’ support for
school-entry requirements for human papillomavirus vaccination: a National
Study. Cancer Epidemiol Biomark Prev. 2016;25(9):1317–25. https://doi.org/1
0.1158/1055-9965.EPI-15-1159.
39. Painter JE, Viana De O. Mesquita S, Jimenez L, Avila AA, Sutter CJ, Sutter R.
Vaccine-related attitudes and decision-making among uninsured, Latin
American immigrant mothers of adolescent daughters: a qualitative study.
Hum Vaccines Immunother. 2019;15(1):121–33. https://doi.org/10.1080/2164
5515.2018.1514353.
40. Luna-Pinto SC, Rivera A, Cardona I, et al. Restoring Immunization Services
Provided by the Vaccines for Children Program in Puerto Rico After
Hurricanes Irma and Maria, 2017–2019. J Public Heal Manag Pract. 2020;
27(6):E228–35. https://doi.org/10.1097/PHH.0000000000001193.
41. Hoss A, Meyerson BE, Zimet GD. State statutes and regulations related to
human papillomavirus vaccination. Hum Vaccines Immunother. 2019;15(7–
8):1519–26. https://doi.org/10.1080/21645515.2019.1627817.
42. U.S. Census Bureau QuickFacts: Puerto Rico. https://www.census.gov/quickfa
cts/fact/map/PR/PST045219. Accessed 17 May 2021.
43. Centers for Disease Control and Prevention (CDC). TeenVaxView | 2019
Adolescent HPV Vaccination Coverage Dashboard. https://www.cdc.gov/va
ccines/imz-managers/coverage/teenvaxview/data-reports/hpv/dashboard/2
019.html. Accessed 11 May 2021.
44. Newman PA, Logie CH, Lacombe-Duncan A, et al. Parents’ uptake of human
papillomavirus vaccines for their children: A systematic review and metaanalysis of observational studies. BMJ Open. 2018;8(4):e019206. https://doi.
org/10.1136/bmjopen-2017-019206.
45. North AL, Niccolai LM. Human papillomavirus vaccination requirements in
US schools: recommendations for moving forward. Am J Public Health.
2016;106(10):1765–70. https://doi.org/10.2105/AJPH.2016.303286.
46. Colón-López V, Vázquez-Otero C, Rivera-Figueroa V, et al. HPV vaccine
school entry requirement in Puerto Rico: historical context, challenges, and
opportunities. Prev Chronic Dis. 2021;18:210035. https://doi.org/10.5888/
pcd18.210035.
47. Gilkey MB, Calo WA, Marciniak MW, Brewer NT. Parents who refuse or delay
HPV vaccine: differences in vaccination behavior, beliefs, and clinical
communication preferences. Hum Vaccin Immunother. 2017;13(3):680–6.
https://doi.org/10.1080/21645515.2016.1247134.

Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.

